Skip to content

Study on the Effect of Repeated Magnetic Brain Stimulation on Jaw Joint Pain in Adults with TMJ Disorder

Effect of High Frequency Repeated Transcranial Magnetic Stimulation on Pain Intensity in Adult Patients with Temporomandibular Mandibular Joint Disorder: A Prospective Cohort Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/06/088641
Enrollment
54
Registered
2025-06-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M266- Temporomandibular joint disorders

Interventions

Intervention1: Nil: Nil

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients above 18-60 years of age. 2. Any gender. 3. Confirmed Temporomandibular joint disorder diagnosis according to DC-TMD Criteria. 4. Chronic TMD pain in the joint region for at least 3 months. 5. Average pain intensity of equal to or more than 4 on a 0-10 VAS scale. 6. Can read and write in Hindi/ English.

Exclusion criteria

Exclusion criteria: 1. Grade V Wilke s classification of TMD 2. Severe psychiatric disorder (suicidal, violent, schizophrenia, mania, severe depression, patient with an indication of admission due to any psychiatric condition). 3. Pregnancy, lactation, unfit for application of TMS i.e., metallic implants, pacemaker, cardiovascular stents, history of severe head injury, etc- contraindications for rTMS as per safety guidelines. 4. Uncontrolled chronic pain conditions other than TMD 5. Severe intellectual disability, seizure disorder, neuroprogressive illness, locomotor difficulty. 6. Clinically unstable.

Design outcomes

Primary

MeasureTime frame
High-frequency rTMS therapy will result in a significant reduction in the pain perception- a decrease in VAS score by 2 on the VAS scale in temporomandibular joint disorder patientsTimepoint: 1. Just after 5 days of therapy 2. After 1 month of therapy 3. After 2 months of therapy

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Manish J Raghani

All India Institute of Medical Sciences, Raipur

drmanishraghani@aiimsraipur.edu.in9691562656

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026